GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » 14-Day RSI

TPIA (Mycotopia Therapies) 14-Day RSI : 58.78 (As of Dec. 12, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-12), Mycotopia Therapies's 14-Day RSI is 58.78.

The industry rank for Mycotopia Therapies's 14-Day RSI or its related term are showing as below:

TPIA's 14-Day RSI is ranked worse than
84.31% of 1523 companies
in the Biotechnology industry
Industry Median: 46.95 vs TPIA: 58.78

Competitive Comparison of Mycotopia Therapies's 14-Day RSI

For the Biotechnology subindustry, Mycotopia Therapies's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycotopia Therapies's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mycotopia Therapies's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Mycotopia Therapies's 14-Day RSI falls into.



Mycotopia Therapies  (OTCPK:TPIA) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mycotopia Therapies  (OTCPK:TPIA) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Mycotopia Therapies 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycotopia Therapies Business Description

Traded in Other Exchanges
N/A
Address
100 SE 2nd Street, Suite 2000, Miami, FL, USA, 33131
Mycotopia Therapies Inc provides psychedelic therapies treatment of mental health issues and supports the creation of both natural and synthetic molecules for the development of appropriate treatments.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336

Mycotopia Therapies Headlines

From GuruFocus

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

By Value_Insider Value_Insider 12-07-2022